Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to CyclophosphamideAtefeh Khodakarami, Farhad Jadidi‐Niaragh, Bentolhoda Rashidi et al.|Cell Communication and Signaling|2023Cited by 16
Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potentialMaryam Farajzadeh, Farhad Jadidi‐Niaragh, Mehrdad Fathi et al.|Cancer Cell International|2025Cited by 11